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Coordination of cell-cell adhesion, actomyosin dynamics and gene expression is crucial
for morphogenetic processes underlying tissue and organ development. Rho GTPases
are main regulators of the cytoskeleton and adhesion. They are activated by guanine
nucleotide exchange factors in a spatially and temporally controlled manner. However,
the roles of these Rho GTPase activators during complex developmental processes are
still poorly understood. ARHGEF18/p114RhoGEF is a tight junction-associated RhoA
activator that forms complexes with myosin II, and regulates actomyosin contractility.
Here we show that p114RhoGEF/ARHGEF18 is required for mouse syncytiotrophoblast
differentiation and placenta development. In vitro and in vivo experiments identify
that p114RhoGEF controls expression of AKAP12, a protein regulating protein kinase
A (PKA) signaling, and is required for PKA-induced actomyosin remodeling, cAMP-
responsive element binding protein (CREB)-driven gene expression of proteins required
for trophoblast differentiation, and, hence, trophoblast cell-cell fusion. Our data thus
indicate that p114RhoGEF links actomyosin dynamics and cell-cell junctions to
PKA/CREB signaling, gene expression and cell-cell fusion.
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INTRODUCTION
Development of tissues and organs is mediated by complex morphogenetic processes that require
remodeling of cell-substrate and cell-cell adhesion, gene expression, as well as dynamic cellular
processes driven by the actomyosin cytoskeleton. Rho GTPases are major regulators of these
processes. They regulate a wide variety of different cellular mechanisms but signal via a relatively
small set of effector molecules; hence, it is thought that the molecular mechanisms that control
their activation and inactivation in space and time determine process-specificity. Activation is
mediated by guanine nucleotide exchange factors (GEFs) that catalyze the exchange of GDP by
GTP. A large number of GEFs forming two protein families, Dbl and DOCK GEFs, have been
identified and characterized in various in vitro systems; however, their functions in tissue and organ
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morphogenesis, and their interactions with major signaling
pathways that drive gene expression and cell differentiation are
not well understood.
Cell-cell adhesion complexes such as tight and adherens
junctions interact with the cytoskeleton and harbor regulatory
proteins that control cytoskeletal dynamics and, thereby, cell
adhesion and behavior. A key group of such signaling proteins
recruited to tight junctions are GEFs for RhoA, which includes
p114RhoGEF/ARHGEF18, GEF-H1/ARHGEF2 and ARHGEF11
(Benais-Pont et al., 2003; Terry et al., 2011; Itoh et al.,
2012; Xu et al., 2013). However, their roles in developmental
morphogenetic processes are still poorly understood. Mutations
in fish indicate that p114RhoGEF may function in the
maintenance, rather than development, of apicobasal polarity
in neuroepithelia (Herder et al., 2013). In humans, partially
inactivating p114RhoGEF mutations lead to retinitis pigmentosa
after apparently normal retinal development (Arno et al., 2017).
A genome-wide SNP analysis also linked p114RhoGEF to
capillary leak syndrome (Clarkson disease) and non-idiopathic
pulmonary arterial hypertension susceptibility; however, the
effects of the SNPs on p114RhoGEF activity, and the underlying
molecular and cellular processes linking p114RhoGEF to vascular
leakage are not known (Xie et al., 2013; Li et al., 2018). Hence, the
roles of p114RhoGEF in cell adhesion dynamics in vivo and tissue
morphogenesis are not known.
Given the role of p114RhoGEF in the regulation of dynamic
cellular processes and the coordination of actomyosin activation
in response to changes in cell adhesion in vitro (Nakajima and
Tanoue, 2011; Terry et al., 2011, 2012; Zihni et al., 2017; Acharya
et al., 2018; Haas et al., 2020), we asked whether such functions
are important for organ morphogenesis. Our data show that
p114RhoGEF is indeed essential for mouse development with
embryos displaying a number of different phenotypes. A main
phenotype observed in p114RhoGEF-deficient mice is the failure
of normal placenta development, a PKA-driven process that
involves cell-cell fusion during syncytiotrophoblast formation,
which requires activation of PKA/CREB-induced expression of
the transcription factor Gcm1 and proteins that act as fusogens,
syncytins, as well as remodeling of the actin cytoskeleton.
Results from knockout mice and cultured trophoblast models
indeed indicate that p114RhoGEF promotes cell-cell fusion by
coordinating actomyosin remodeling and PKA/CREB-regulated
expression of proteins required for cell-cell fusion.
MATERIALS AND METHODS
Mouse Lines
ARHGEF18/p114RhoGEF knockout mice containing a gene
trap insertion ablating expression were purchased from
(EMMA)1and animals carrying the conditional knockout
first (promoter driven) ARHGEF18TM1a(KOMP) allele were
obtained from the Knockout Mouse Project (KOMP)2.
ARHGEF18/p114RhoGEF knockout mice were crossed into
1https://www.taconic.com/knockout-mouse/arhgef18-trapped
2https://www.komp.org/geneinfo.php?geneid=23667
a C57BL/6N genetic background for more than 6 generations.
Animals carrying the conditional knockout first (promoter
driven) ARHGEF18TM1a(KOMP) allele were also crossed into
a C57BL/6N genetic background. The lacZ/neo cassette was
removed by crossing with mice carrying the Flippase gene.
To generate endothelial-specific knockouts, animals carrying
the conditional allele were crossed with mice harboring the
Tie2-Cre driver (kindly provided by Professor Christiana
Ruhrberg) (Kisanuki et al., 2001; Erskine et al., 2017). Animals
were housed in individually ventilated cages and facilities were
regularly monitored for health status. Use of all animals was in
accordance with UK Home Office regulations, the UK Animals
(Scientific Procedures) Act of 1986 and was approved by the
Institute’s Animal Welfare and Ethical Review Body. The number
of mice per experimental group was kept to the minimum
to reach statistical significance and ensure reproducibility in
accordance with NC3R recommendations. Timed pregnancies
were monitored by counting the day of the vaginal plug as E0.5
and pregnant females were sacrificed and dissected from E10.5
through E15.5. The pregnant mice were first euthanized and
their uteri were removed by cutting at the cervix. Placentas and
embryos were collected and imaged for phenotyping. Tail samples
were collected for genotyping by PCR using genomic DNA and
primer 5′-ATCCAGTAACTACCATACCCACCC-3′ together
with primer 5′- GGCTTAGACGAACAGGAGTTCCAAG-
3′ for the wild type allele and with primer 5′-
TATTCAGCTGTTCCATCTGTTCCTGACC-3′ for the
mutant allele. The floxed allele was detected with 5′-
ATTTTTGTCTGCATGTATGTCTGTGC-3′ and 5′-GAGATG
GCGCAACGCAATTAATG-3′, and Tie2-Cre with 5′-
GCCTGCATTACCGGTCGATGC-3′ and 5′-CAGGGTGTTAT
AAGCAATCCCC-3′. Placentas and embryos were imaged with
a Nikon SMZ1500 stereomicroscope equipped with a Plan Apo




Placentas were fixed in 4% PFA, frozen in OCT-embedding
compound and cryo-sectioned. Consecutive 12 µm cryosections
were produced and alternately mounted on different slides.
A series of sections per block was processed for hematoxylin
and eosin (H&E) staining. For immunofluorescence, cryosections
were permeabilized with 0.5% Triton X-100 and 0.1% Saponin
in PBS and then blocked with 1% donkey serum in 0.1%
TritonX-100 and 0.02% Saponin in PBS. Primary antibodies
were incubated overnight at 4◦C in blocking solution. Secondary
antibodies were then also incubated in blocking solution,
followed by washing with PBS and mounting with Prolong Gold
antifade reagent (Life technologies). Cells were fixed either with
methanol at –20◦C for 5 min, 95% ethanol for 10 mins at –20◦C,
or with 3% PFA for 20 min at room temperature followed by 0.3%
Triton X-100 permeabilization for 5 min (Balda et al., 1996). The
cells were then washed with PBS and incubated in blocking buffer
(PBS containing 0.5% BSA) for 15 min prior to labeling with
primary antibodies in the same buffer (Tornavaca et al., 2015).
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After an overnight incubation at 4◦C, cells were washed
three times with blocking buffer and then incubated with the
secondary antibodies in the same buffer for at least 2 h. After
three washes with PBS, the coverslips were mounted with
ProLong Gold mounting medium (Invitrogen) and stored at 4◦C
(Elbediwy et al., 2012). Images were taken with an epifluorescence
microscope (Zeiss Axioscope) using a 40 × /1.4 NA objective
lens and a Hamamatsu Photonics camera C4742-95 camera using
simple PCI software (Hamamatsu Photonics). Brightness and
contrast were adjusted with Photoshop CS4 and CC (Adobe).
Fluorescence intensity and placenta parameters were quantified
with ImageJ/Fiji software. For fusion index quantification, the
number of nuclei in fused cells was expressed as a percentage
of the total nuclei in the field of view. For placenta staining
quantification, MCT4 positive areas were measured in at least
two images taken at a 10x magnification per placenta. For
F-actin ratios, mean immunofluorescence rations were measured
and ratios of lateral divided by basal (internal) staining were
calculated. To do so, a mask was created containing the edge of
the cells to determine cortex intensity. The mean fluorescence
intensity within this mask was used to calculate mean cortical
F-actin intensity, while mean fluorescence intensity outside this
mask (i.e., intracellular) was used to represent intracellular
F-actin stress fibers. For immunoblotting, cells were washed twice
with PBS, lysed in SDS-PAGE sample buffer, and denatured at
70◦C for 10 min (Sourisseau et al., 2006). The samples were then
homogenized with a 1 ml syringe and a 25G needle, proteins were
separated by SDS-PAGE and transferred onto PVDF membranes
(Steed et al., 2014). For immunoblotting of E12.5 placentas
and embryos, whole tissue samples were homogenized in 6 M
Urea, protein content quantified, diluted in 3XSDS-PAGE sample
buffer and separated in mini-gels. The membranes were blocked
with 5% defatted milk powder dissolved in TBS containing 0.1%
Tween-20 and then incubated with primary antibodies overnight
in the same solution or, for anti-phospho-protein antibodies, 5%
BSA dissolved in TBS containing 0.1% Tween-20. After washing,
the primary antibodies were detected with HRP-conjugated or
fluorescent secondary antibodies using either an ECL detection
system or Li-Cor ODYSSEY infrared imaging system (Steed et al.,
2014). See Supplementary Table S1 for details of antibodies used.
In situ Hybridization
In situ hybridization was performed in 12-µm placenta
cryosections using digoxygenin (DIG) labeled probes and an anti-
DIG-alkaline phosphatase detection system. Probes for Tpbpa,
Hand1, Gcm1, and SynA were kindly provided by Professor
James Cross and used as previously described (Supplementary
Table S1; Simmons et al., 2007). The p114RhoGEF probe
for in situ hybridization was custom-designed to be used
with the ViewRNA system, which was used according to the
manufacturer’s instructions (ThermoFisher). Briefly, frozen OCT
12 µm placenta sections were dehydrated through ethanol (50–
70–100%) and then baked dry for 1 h at 60◦C. Samples were then
treated with proteinase for 5 min, fixed in 4% formaldehyde and
then incubated with p114RhoGEF viewRNA probe overnight at
40◦C in a humidified chamber. The following day, samples were
incubated with pre-amplification and amplification probes for 1 h
and 30 min, respectively, at 40◦C. A final step to label the reaction
with alkaline phosphatase was performed at 40◦C. Samples were
then subjected to a final wash before incubation with substrate
overnight to allow purple precipitate to develop.
Cell Culture and RNA Interference
Human dermal microvascular endothelial cells were purchased
form Promocell (HDMEC-c adult C-12212). The wild-
type mouse TS-Rs26 trophoblast stem cell (TSC) line was
kindly provided by Professor Myriam Hemberger (Latos
et al., 2015; Murray et al., 2016). BeWo cells were described
previously (Delidaki et al., 2011). Fresh batches of cells from a
contamination-free stock that had been tested for mycoplasma
were used to replace fresh cultures every 6–8 weeks. Human
dermal microvascular endothelial cells were maintained on
gelatine (G1393; Sigma-Aldrich)-coated tissue-culture Petri
dishes in endothelial cell growth Medium MV2 (Promocell)
(Tornavaca et al., 2015). Cells were used between passage two
and four. The TS-Rs26 TSC line was maintained in 70% volume
mouse embryonic fibroblasts (MEF) conditioned medium
(CM, collected from Mitomycin-C treated MEFs), 30% volume
RPMI-1640 containing 20% fetal bovine serum, 1% non-essential
amino acids, 1% sodium pyruvate and 0.1% β-mercaptoethanol,
supplemented with FGF 50 ng/ml and Heparin 1 µg/ml as
previously described (Murray et al., 2016). BeWo cells were
maintained in 50% F12K/50% DMEM medium supplemented
with 15% fetal bovine serum. Cells were passaged every 3–4 days
at subconfluency and medium was changed daily. For RNA
interference, siRNA stocks were diluted to 20 µM and were
transfected with Lipofectamine RNAiMax reagent (Invitrogen)
according to manufacturer’s instructions using final siRNA
concentration of 20–80 nM. Cells were collected for analysis after
72–96 h post-transfection. The following siRNA sequences were
used: human p114RhoGEF 5′-UCAGGGCGCUUGAAAGAUA-
3′ and 5′-GGACGCA ACUCGGACCAAU-3′; mouse
p114RhoGEF 5′-GCAUCAUCCAGAACACAGA-3′, 5′-CAGA
UUCUCAGAUCGGCCA-3′ and 5′-CACAUGAGUUUGAGGC
CGA-3′; and human AKAP12 5′-UCUGCAGAAUCUC
CGACUA-3′ and 5′-AGACGGAUGUAGUGUUGAA-3′.
Non-targeting control siRNAs were 5′-UGGUUUACAUG
UCGACUAA-3′ and 5′-UGGUUUACAUGUUGUGUGA-3′.
All siRNAs were synthesized by Sigma-Aldrich with
dTdT 3′-overhangs.
Stem Cell Differentiation, Cell Fusion,
and Migration
To induce TSC line cell differentiation, cells were cultured in
RPMI-1640 containing 1 µM CHIR99021 inhibitor for 72 h.
To induce BeWo cell-cell fusion, cells were treated with the
adenyl cyclase activator forskolin (100 µM) for the indicated
times. DMSO was used to dissolve CHIR99021 and forskolin and
used as solvent control. For analysis of migration, TSCs were
grown to confluency and a cross-scratch wound was induced
in the monolayer using a pipette tip, and debris was removed
by washing once in culture medium. Cell monolayers were
then imaged after 0, 24, and 48 h in medium with fetal calf
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serum (FCS) to observe wound closure. Percentage wound area
was calculated by manual tracking of the wound edges using
Fiji/ImageJ software. In each of the repeat experiments, three
scratch wounds were analyzed.
RNA Isolation and qPCR
After 72–96 h protein depletion by siRNA, cells were washed
once with PBS and then lysed for RNA extraction using the
PureLink RNA Mini Kit (Thermo Fisher Scientific). cDNA was
synthesized using the QuantiTect Reverse Transcription Kit
(Qiagen). Real time quantitative PCR (qPCR) was performed
using PowerUp SybrGreen Master Mix (Thermo Fisher
Scientific) and the QuantStudio 6 Real-Time PCR System
(Applied Biosystems). GAPDH was amplified as a control
to normalize the data. The following primers were used:
mouse SynA 5′-CTCCAGGAGGCTAACTCTTCC-3′ and
5′-TCCGGGCTGAGTACATGATTC-3′; mouse SynB 5′-TG
GGTCCTCTGTTTCGTCCTT-3′ and 5′-GGGAAGAGTTGGT
ATCACGTAGG-3′; mouse Gcm1 5′-AGAGATACTGAGCT
GGGACATT-3′ and 5′-CTGTCGTCCGAGCTGTAGATG-3′;
mouse ARHGEF18 5′-TCAGACAGAAGTGTGGTCCG-3′
and 5′-GGAGACTGCGAGAGCGAC-3′ or 5′-TTGTGCG
AAGGCTGGGAG-3′ and 5′-GGATGATGCGTTCCACAAGC-
3′; mouse Tpbpa 5′-ACTCCCAGGCATAGGATGAC-3′ and
5′-TGAAGAGCTGAACCACTGGA-3′; mouse Hand1 5′-CT
TTAATCCTCTTCTCGCCG-3′ and 5′-TGAACTCAAAAAGAC
GGATGG-3′; mouse Cdx2 5′-TCTGTGTACACCACCCGGTA-
3′ and 5′-GAAACCTGTGCGAGTGGATG-3′; mouse Ctsq
5′-GTGTTTCAGCATTTGATCCCAGT-3′ and 5′-GTCAGCAA
ACCCATTTAATCCCA-3′; mouse Ehox 5′-GGTGATGCAGA
CCTCATGGAT-3′ and 5′-GATACCAGCACTGGAATAGGC-3′;
mouse Elf5 5′-CTGGTCACAGCAGAATTGGA-3′ and 5′-
CTGCCTTTGAGCATCAGACA-3′; Ascl2 5′-AAGCACACCT
TGACTGGTACG-3′ and 5′-AAGTGGACGTTTGCACCTTCA-
3′; mouse Tcfeb 5′-GGAGCCAGAGCTGCTTGTTA-3′ and
5′-CAAGGCCTCTGTGGATTACA-3′; mouse Mdfi 5′-CTG
GGACCTGGAGAAAACAG-3′ and 5′-CGCAGCTTGCACGAG
TATG-3′; mouse Prl3d1 5′-GGTGTCAAGCCTACTCCTTTG-
3′ and 5′-GTATTATGGAGCAGTTCAGCCAA-3′; mouse
Prl3b1 5′-CACCAGACAACATCGGAAGAC-3′ and 5′-TGAC
AGCAGAGTATCAGGTACA-3′; mouse Prl2c2 5′-TCCTG
GATACTGCTCCTACTACT-3′ and 5′-AGCCCAGACACGTT
AGAATAATG-3′; human AKAP12 5′-GGACCCCCTTTCT
GAGAGAC-3′ and 5′-CAGACACCACCGCGGAC-3′; human
Gcm1 5′-TTCCCGGTCACCAACTTCTG-3′ and 5′-GTAAACT




BeWo cells were plated into 96 well dishes at 5,000 cells per
well and after 24 h transfected with control, p114RhoGEF
or AKAP12 siRNAs. To measure CREB activity, a plasmid
containing a cAMP response element binding site driving firefly
luciferase was transfected with a control plasmid containing a
CMV promotor driving renilla luciferase expression using the
TransiT-X2 transfection reagent (Mirus Bio) 48 h after the siRNA
transfection. Firefly and renilla luciferase activity were measured
24 h later using the dual luciferase assay kit (Promega).
Human Chorionic Gonadotropin (hCG)
Secretion Assay
BeWo cells were grown in 6-well plates until a confluency
of about 70%. Cells were then incubated for 24 h prior
to hormone collection. Control cultures received the DMSO
vehicle in the same concentration as the forskolin-treated
cultures. The medium was collected after 24 h of incubation.
Supernatants were aspirated, centrifuged at 500 g for 5 min
at 4◦C to remove cell debris, and stored at –80◦C until
analysis. The amount of secreted hCG was determined by the
Department of Biochemistry (University Hospitals Coventry and
Warwickshire NHS Trust) using the Elecsys R© Intact hCG + b
electrochemiluminescence immunoassay (ECLIA) and the fully
automated modular analytics E170 testing system from Roche
Diagnostics (Mannheim, Germany). Results were expressed as
IU/ml per 105 cells.
Statistics and Reproducibility
For the quantifications shown, the provided n values refer to
the numbers of embryos or placentas analyzed in the mouse
experiments or, for the experiments with cell lines, the number
of repeat experiments. The data shown are individual data
points along with a value representing the median or mean
as indicated. Statistical significance was tested with two-tailed
t-tests, ANOVA and Tukey HSD tests, or Kruskal-Wallis and
Wilcoxon non-parametric tests as indicated using either Prism
or JMP Pro (V15) software.
RESULTS
p114RhoGEF Is Required for Mouse and
Placenta Development
We tested whether p114RhoGEF is important for mammalian
embryonic development in a global p114RhoGEF knockout
mouse strain (p114−/−) from EMMA (ID EM:02310) that
carries a retroviral gene trap insertion in the intron before the
first coding exon (Figure 1A). Immunoblotting of embryos at
E12.5 revealed that the insertion resulted in efficient knockout
of p114RhoGEF protein expression (Figure 1B). Analysis of
born litters from mating heterozygous mice revealed that
no p114−/− mice were born (Supplementary Figure 1A),
indicating embryonic lethality. During embryonic development,
the expected numbers of p114−/− embryos were present at
E11.5 and E12.5 (Figure 1C), but by E15.5 the number
of p114−/− embryos was strongly reduced. More detailed
analysis of the phenotypes of p114−/− embryos at E10.5/11.5
and E12.5/13.5 revealed various phenotypes including anemia,
abdominal hemorrhages and effusions as well as yolk sac
edema and vascular defects (Figures 1D,E and Supplementary
Figures 1B,C). At E12.5, a large number of embryos had
placenta defects and/or exhibited growth arrest or resorption
(Figures 1D,E). Placenta defects are a common cause of
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FIGURE 1 | Knockout of p114RhoGEF in mice is embryonic lethal. (A) Schematic representation of mutation strategy for generating the ARGEF18/p114 KO mouse
(adapted from https://www.taconic.com/knockout-mouse/arhgef18-trapped). Indicated is the insertion site of the trapping cassette prior to the start initiation codon.
(B) Immunoblot of samples generated from E12.5 embryos, indicating complete ablation of p114RhoGEF expression in p114−/− embryos. (C) Analysis of embryos
at E11.5, E12.5 and E15.5. Genotypes at E12.5 were at expected mendelian ratios but by E15.5, the percentage of p114−/− embryos started to decrease due to
embryonic arrest. (D,E) Analysis of p114−/− phenotypes at E11.5 and representative images of phenotypes observed. (F) Analysis of embryo and placenta weights
at E12.5. Shown are data points and means. Significance was tested with t-tests. (G) Hematoxylin and eosin (H&E) staining of 12µm placenta cryosections at
E12.5. Note the decrease in thickness of the labyrinth layer in p114RhoGEF-deficient animals (asterisks). Junctional zones are indicated with dashed lines.
(H) Quantification of placenta morphology from H&E sections. Shown are data points and means, n = 6 placentas per genotype. Paired t-tests were used to
determine significance of differences observed in different litters. Bars: (G), upper panel 1 mm and lower panel 0.5 mm.
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embryonic lethality in mouse mutants because of its importance
in maternal-fetal nutrient exchange (Perez-Garcia et al., 2018).
Hence, defects in placenta development—although they may not
be the only reason for embryonic death—are likely to make
an important contribution to the lethality of p114RhoGEF-
deficient embryos.
Placenta development involves contributions by the mother
and the developing embryos, and requires dynamic cellular
processes, including cell migration and invasion, as well as
remodeling of cell-cell junctions and cell-cell fusion; hence,
placenta development is an ideal organ to study the importance
of p114RhoGEF in cell dynamics. Fetal development is regulated
through placental growth during mid-gestation. At E12.5,
p114−/− placentas were found to be significantly weight-
reduced compared to wild-type littermate controls, which
correlated with the reduced weight of the embryos (Figure 1F).
At E12.5, the three main layers of the placenta are the
maternal decidua basalis and the embryo-derived junctional
zone and labyrinth. Placentas from p114−/− embryos were
paler with less blood in the labyrinth zone, suggesting impaired
vascularization, and the junctional zone width was reduced
and had significantly fewer number of invasions into the
labyrinth (Figures 1G,H and Supplementary Figure 1D). Thus,





Placenta development depends on the differentiation of
trophoblast stem cells (TSCs) into various subtypes of
trophoblasts to form the junctional zone and the labyrinth.
Markers of initial trophoblast differentiation from trophoblast
stem cells (Cdx2) into spongiotrophoblasts and giant cells of
the junctional zone (Acsl2 and Hand1, respectively) were not
significantly affected by loss of ARHGEF18, suggesting no defect
in the initial differentiation of TSCs (Figure 2A). In contrast,
markers of the labyrinth syncytiotrophoblast cells SynT-I
and SynT-II (the transcription factor Gcm1 and the fusogenic
proteins SynA, and SynB) were reduced in p114RhoGEF deficient
placentas (Figure 2A). Markers of TSCs and trophoblasts other
than labyrinth syncytiotrophoblasts were unaltered or increased
(Supplementary Figure 2). In situ hybridization confirmed the
observations made by qPCR and revealed strong expression
of p114RhoGEF in the labyrinth zone of wild type but not
knockout mice: no changes in Tpbpa and Hand1 but reduced
staining for GCM1 and SynA were observed (Figure 2B).
Immunofluorescence indicated expression of p114RhoGEF in
the labyrinth layer in both endothelia (Isolectin B4, Figure 2C)
and the neighboring syncytiotrophoblasts (MTC4, Figure 2D).
Hence, the expression pattern of p114RhoGEF is compatible with
a role in labyrinth trophoblasts and endothelia. The attenuation
of formation of labyrinth trophoblast subtypes thus provides an
explanation for the defective development of the labyrinth in the
absence of p114RhoGEF. SynT-I and SynT-II cells are critical
for the morphogenesis of the embryonic labyrinth sinusoids,
which facilitate effective fetal-maternal nutrient/gas exchange.
Intriguingly, Isolectin-B4 staining, which marks blood vessels,
appeared to be at similar levels in control and knockout tissue,
but the vessels appeared more loosely organized in p114RhoGEF
knockout mice, suggesting that blood vessels were still present
(Figure 2D). In contrast, staining for MCT4, a marker for
SynT-II cells, revealed a highly organized and compact labyrinth
structure in wild type placentas, but MCT4 expression appeared
weak and covered less area in p114−/− placentas (Figure 2D).
Other endothelial markers such as laminin and CD31/PECAM
revealed similar changes as Isolectin-B4: a more disordered
appearance but at similar expression levels. However, markers
expressed by labyrinth syncytiotrophoblasts and endothelial cells
(β-catenin, Vegfr2) or syncytiotrophoblasts only (E-cadherin)
appeared also downregulated (Supplementary Figure 3),
suggesting that syncytiotrophoblasts, but not endothelial cells,
are reduced in the labyrinth layer of p114RhoGEF deficient
placentas. Similarly, staining of myosin II, a protein that
associates with p114RhoGEF, revealed unaltered in areas positive
for the endothelial marker Isolectin-B4 but appeared reduced
in Isolectin-B4 negative cells (Supplementary Figure 3D).
Disrupted labyrinth organization was also suggested by the
altered alpha-smooth muscle actin staining, a marker of
placental pericytes (Supplementary Figure 3E; Ohlsson et al.,
1999). These results indicate that p114RhoGEF plays a role in
syncytiotrophoblast differentiation and blood vessel organization
in the labyrinth layer of the placenta but appears to have a
stronger impact on syncytiotrophoblasts.
p114RhoGEF Regulates Endothelial
Actomyosin Organization
ZO-1 recruits p114RhoGEF to cell-cell junctions in primary
human microvascular endothelial cells (HDMECs) via an
interaction with JACOP, a junctional adaptor protein (Tornavaca
et al., 2015). Hence, the disorganization of blood vessels in the
placenta labyrinth of p114RhoGEF-deficient embryos could be
due to a role of p114RhoGEF in endothelial cell-cell junctions
and/or to the deficiency in syncytiotrophoblasts. Therefore, we
first tested the role of p114RhoGEF in cultured endothelial
cells. Depletion of the Rho GEF in primary endothelial cells
by RNA interference indeed induced a remodeling of the actin
cytoskeleton with reduced cortical F-actin at cell-cell junctions
and increased stress fibers (Figures 3A–E). This was associated
with a redistribution of active myosin, as detected by staining
for double phosphorylated myosin light chain 2 (ppMLC), from
cell junctions to stress fibers (Figure 3D). While components of
adherens (VE-Cadherin, p120-catenin and PECAM) and tight
(ZO-1, JAM-A, and JACOP) junctions were still recruited to
cell-cell contacts in p114RhoGEF depleted endothelia, junctions
appeared irregular and had lost their linear structure, suggesting
altered junctional tension (Figures 3B,F,G). The tight junction
plaque proteins ZO-1 and JACOP were affected more strongly
with apparent gaps along the junctions (Figure 3B; Tornavaca
et al., 2015). These results indicate that p114RhoGEF depletion
in endothelial cells in vitro interferes with the normal localization
of cell-cell junction proteins and the actin cytoskeleton.
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FIGURE 2 | p114RhoGEF is required for labyrinth syncytiotrophoblast differentiation. (A) RNA expression analysis of p114RhoGEF and markers for stem cells
(Cdx2), spongiotrophoblasts (Ascl2), trophoblast giant cells (Hand1), and syncytiotrophoblasts (Gcm1, SynA, and SunB). Data were normalized to wild type controls
in each litter. Shown are data points, means and p-values derived from t-tests (B) E12.5 control and p114−/− placenta cryosections (12 µm) were analyzed by
in situ hybridization. p114RhoGEF was preferentially expressed in the labyrinth layer and expression was lost in knockout placentas. Of the trophoblast markers, only
the syncytiotrophoblast markers Gcm1 and SynA were reduced in p114− placentas. Indicated are the main layers of the placenta: the maternal decidua basalis (DB)
and the embryo-derived junctional zone (JZ) and labyrinth (L). (C) Immunofluorescence analysis of p114RhoGEF expression in placenta cryosections in comparison
to Isolectin B4 staining of endothelial cells. Note, p114RhoGEF staining, which is lost in knockout placentas, overlaps with but is not restricted to endothelial cells.
(D) Staining of MCT4 and Isolectin B4 in placenta cryosections reveals a disorganized appearance of endothelia-lined blood vessels and a reduced expression of the
syncytiotrophoblast marker MCT4. The graph shows a quantification of MCT4-positive areas, indicating syncytiotrophoblasts, in placenta sections derived from 3
different embryos (the p-value is based on a t-est). Bars: (B), 0.5 mm; (C), 50 µm; (D), 0.2 mm
p114RhoGEF Stimulates AKAP12
Expression in Endothelial Cells and
Placentas but Endothelial GEF Is Not
Essential for Development
PKA signaling stabilizes epithelial and endothelial barriers
(Matter and Balda, 2003). Given the link of p114RhoGEF to
Clarkson disease (Xie et al., 2013) and the fraction of embryos
with hemorrhages we observed, we asked whether p114RhoGEF
cooperates with signaling proteins required for endothelial
barrier stability. Several factors contribute to endothelial barrier
stability with AKAP12 having been suggested to be involved
in PKA-mediated barrier formation (Radeva et al., 2014).
AKAP12 is a tumor suppressor gene and A kinase anchoring
Frontiers in Cell and Developmental Biology | www.frontiersin.org 7 March 2021 | Volume 9 | Article 658006
fcell-09-658006 March 19, 2021 Time: 12:34 # 8
Beal et al. p114RhoGEF in Placenta Morphogenesis
FIGURE 3 | p114RhoGEF depletion in endothelial cells leads to rearrangement of the actin cytoskeleton. HDMECs were transfected with control or
p114RhoGEF-targetig siRNAs prior to analysis by immunofluorescence (A,D,F,G) or immunoblotting (B) using antibodies against (A) 114RhoGEF; (D) double
phosphorylated myosin regulatory light chain (ppMLC) and Myosin-IIA heavy chain; (F) the adherens junction proteins VE-Cadherin, p120-catenin, and PECAM-1;
and (G) the tight junction proteins ZO-1, JAM-A, and JACOP. Fluorescently labeled phalloidin was used to label F-actin. Expression of p114RhoGEF was quantified
and calculated as a ration to α-tubulin expression (C). Redistribution of F-actin was quantified by calculating ratios of lateral vs. basal F-actin intensity (E).
Quantifications are based on three independent experiments and p-values were calculated with t-tests. Bars: 40 µm.
protein family member that regulates cytoskeletal and cell-
cycle signaling pathways (Akakura et al., 2008; Radeva et al.,
2014). Thus, we tested whether p114RhoGEF depletion affects
AKAP12 expression. AKAP12 mRNA was downregulated by
p114RhoGEF depletion as determined by RT-qPCR (Figure 4A).
By immunoblotting, p114RhoGEF expression was not affected
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FIGURE 4 | p114RhoGEF depletion suppresses AKAP12 expression in endothelial cells and placentas but endothelial specific deletion does not affect embryonic
viability. (A) p114RhoGEF depletion represses expression of AKAP12 mRNA as assessed by RT-qPCR. Data were normalized to wild type controls in each litter.
Shown are data points derived from different placentas, means and p-values derived from t-tests. (B–E) HDMECs were transfected with siRNAs as indicated and
then processed for (B) immunoblotting or (C,D) immunofluorescence for the indicated markers. Note, AKAP12 depletion induces a strong reorganization of the actin
cytoskeleton and reduced JACOP expression reminiscent of the effect of p114RhoGEF depletion. Expression of p114RhoGEF was quantified and calculated as a
ration to α-tubulin expression (C). Redistribution of F-actin was quantified by calculating ratios of lateral vs. basal F-actin intensity (p-values are derived from ANOVA
and Tukey HSD tests). (F) AKAP12 staining in cryosections of placentas from wild type and p114RhoGEF deficient mice. Note the strong repression of AKAP12
expression by p114RhoGEF depletion in vitro and in vivo. (G) Analysis of litter genotypes derived from inter-crossing mice harboring the conditional p114RhoGEF
allele (p114f/f) and Tie2-Cre for endothelial specific knockouts. Expected numbers of p114f/f Tie2-Cre mice were born indicating that endothelial p114RhoGEF
deficiency did not impede embryonic development. Bars: (C,D), 40 µm; (E), 0.2 mm.
by AKAP12 knockdown (Figure 4B). Unfortunately, we
could not obtain reliable immunoblots for AKAP12 despite
testing multiple antibodies. Immunofluorescence experiments
demonstrated AKAP12 localization to cell-cell junctions in
control HDMECs; this signal was lost upon AKAP12 depletion
with siRNAs, confirming staining specificity (Figure 4C). As
expected from the mRNA expression analysis, the AKAP12
staining was also strongly reduced in p114RhoGEF depleted
HDMECs (Figures 4A,C). Strikingly, depletion of AKAP12 by
RNA interference in HDMEC led to a similar reorganization of
the actomyosin cytoskeleton as p114RhoGEF depletion: F-actin
was redistributed from cell-cell contacts to stress fibers and the
tension sensitive protein vinculin moved from cell junctions to
focal adhesions (Figures 4D,E). Similarly, JACOP localization
was disrupted and β-catenin staining was less linear at the
junctions although not to the extent as in p114RhoGEF-
depleted cells (Figure 4C). Thus, AKAP12 is a key target
and effector of p114RhoGEF signaling in endothelial junction
assembly and regulation of the actin cytoskeleton. JACOP is the
protein responsible for p114RhoGEF recruitment to endothelial
tight junctions (Tornavaca et al., 2015). Hence, AKAP12
provides a feedback signal to p114RhoGEF by regulating
junction localization of the component mediating junctional
recruitment of the Rho GEF.
As PKA signaling plays an important role in the initiation
of trophoblast cell fusion during placenta formation
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(Gerbaud and Pidoux, 2015), we next stained placenta sections
for AKAP12 to determine whether downregulation of AKAP12
protein also occurred in vivo in p114RhoGEF deficient placentas.
AKAP12 was found to be widely expressed in the labyrinth
zone of the placenta and was strongly reduced in the absence
of p114RhoGEF (Figure 4F). Thus, AKAP12 expression is
p114RhoGEF-dependent in vitro and in vivo.
The observed in vitro effects of p114RhoGEF depletion
suggest that p114RhoGEF deficiency in mice may lead to
vessel malfunction in the placenta and the embryo itself
due to endothelial defects, causing the observed abdominal
hemorrhages in a fraction of the knockout embryos. However,
the embryonic blood vessel integrity defects were modest, arguing
against a general failure of endothelial cells. To test if endothelial
p114RhoGEF is required for embryonic development directly,
we generated endothelial-specific p114RhoGEF knockout mice
using a conditional p114RhoGEF/ARHGEF18 allele (p114flox)
and Tie2-Cre mice. Analysis of litters born from such mice
revealed the expected numbers of mice carrying the conditional
allele and Tie2-Cre (Figure 4G and Supplementary Figure 4).
Hence, endothelial specific knockout of p114RhoGEF does not
lead to embryonic death.
p114RhoGEF Determines Trophoblast
Actomyosin Organization and Drives
Migration and Differentiation
As endothelial knockout of p114RhoGEF did not affect viability
but the global knockout strongly affected the differentiation of
labyrinth syncytiotrophoblasts during placenta development
(Figure 2), we next asked whether the RhoA activator functions
in trophoblast differentiation. To study how p114RhoGEF-
deficiency impacts on the regulation of trophoblast stem
cell (TSC) migration and differentiation, we used the
murine TSC line TS-Rs26 (Tanaka et al., 1998). Depletion
of p114RhoGEF with mouse specific siRNAs induced stress fibers
and redistribution of vinculin, similar to what we had observed in
endothelial cells (Figures 5A,B and Supplementary Figure 5A).
Adherens junctions were only weakly affected (Figure 5B and
Supplementary Figure 5B). Placental development requires
TCS migration; thus, we performed cell migration scratch
assays on confluent monolayers. p114RhoGEF depletion by RNA
interference resulted in significant reduction in wound closure by
48 h (Figure 5C), indicating a reduced migratory capacity. This
is in agreement with a previous study in which we demonstrated
that p114RhoGEF depletion reduces cell migration of corneal
epithelial cells and tumor cell invasion (Terry et al., 2012). Thus,
p114RhoGEF regulates TSC migration providing a possible
explanation for the reduced trophoblast invasions observed in
knockout placentas.
We next asked whether p114RhoGEF-depleted TSCs
can differentiate into labyrinth-specific trophoblast lineages.
Induction of syncytiotrophoblast II cells (SynT-II) was achieved
by GSK3β inhibition with CHIR9902 (Zhu et al., 2017). As
expected, induction of differentiation resulted in downregulation
of the TSC marker Cdx2 in control and p114RhoGEF-depleted
cells; however, induction of SynB, a marker for SynT-II cells,
was attenuated by p114RhoGEF depletion (Figure 5D). In
contrast, expression of Ctsq, a sinusoidal trophoblast giant cell
marker, was enhanced in the absence of p114RhoGEF. Thus,
p114RhoGEF deficiency reduced SynB expression in TSCs
stimulated to differentiate into labyrinth syncytiotrophoblast
and in the placenta in vivo. Induction of differentiation does
not only induce expression of syncytiotrophoblast markers, but
also cell-cell fusion. Strikingly, GSK3β inhibition resulted in the
formation of large fused, multinucleated cells in controls but not
when p114RhoGEF was depleted, suggesting that p114RhoGEF
may not only be required for efficient expression of SynB but also
cell-cell fusion (Figures 5E,F).
p114RhoGEF Regulates cAMP-Induced
Cell-Cell Fusion
Trophoblast cell-cell fusion is initiated by a cAMP signaling
network (Gerbaud and Pidoux, 2015). AKAP12 is upregulated
during forskolin induced cell-cell fusion although it is not
known if it is required for fusion (Delidaki et al., 2011).
Hence, we next asked whether p114RhoGEF and AKAP12
regulate cell-cell fusion using the human trophoblast-like
BeWo cell line in which stimulation of PKA with forskolin
induces cell-cell fusion and enhanced human chorionic
gonadotropin (hCG) secretion (Delidaki et al., 2011). In
control cells, forskolin treatment for 48h induced cell-cell
fusion as observed by cell-cell junctions and actin cytoskeleton
rearrangement that started to delineate the periphery of large
multinucleated fused cells (Figure 6A and Supplementary
Figure 6). Depletion of p114RhoGEF or AKAP12 by RNAi
resulted in a strong reduction of fused cells (Figures 6A,B
and Supplementary Figure 6). No breakdown of junctions as
in control cells was observed. As expected from the in vivo
experiments, forskolin strongly induced Gcm1 mRNA and
protein expression in control RNAi transfected cells but
only weakly in p114RhoGEF-depleted cells, indicating that
defective fusion was paralleled by a loss in Gcm1 induction
in p114RhoGEF depleted cells, further supporting defective
syncytiotrophoblast differentiation (Figures 6C,D). Thus,
p114RhoGEF and its downstream effector AKAP12 are required
for cAMP-induced labyrinth trophoblast gene expression and
cell-cell fusion, processes essential for syncytiotrophoblast
differentiation and placenta formation.
Forskolin activation of cell-cell fusion and hormonogenesis
involves PKA/CREB activation to drive expression of genes
required for syncytiotrophoblast differentiation (Delidaki et al.,
2011). Forskolin treatment for 30 min upregulated levels of
phosphorylated CREB; depletion of p114RhoGEF or AKAP12
attenuated CREB phosphorylation levels and nuclear staining
(Figures 6E,F). In agreement, depletion of either protein also
inhibited CRE-mediated transcription in a luciferase reporter
gene assay (Figure 6G), as well as induction of human
chorionic gonadotropin (hCG) release at 24 h (Figure 6H). Thus,
p114RhoGEF and its downstream partner AKAP12 are required
for efficient PKA/CREB pathway activation to induce cell-cell
fusion as well as expression of PKA/CREB-dependent target
genes required for syncytiotrophoblast differentiation.
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FIGURE 5 | p114RhoGEF regulates trophoblast differentiation. (A) Depletion of p114RhoGEF in siRNA-transfected TS-Rs26 cells was analyzed by immunoblotting
and immunofluorescence. (B) Analysis of the tight junction protein ZO-1, the adherens junction protein p120-catenin, and F-actin in control and
p114RhoGEF-targeting siRNA transfected TS-Rs26 cells by fluorescence microscopy. (C) Cell migration analyzed by scratch wound closure after 0, 24, and 48 h in
TS-Rs26 cells transfected with siRNAs as indicated. Percentage of wound closure was calculated at each time point and plotted from three independent
experiments. Shown are data points, means and p-values derived from t-tests. (D) Expression of trophoblast lineage markers in cells kept in standard maintenance
medium (CM70% + +) or upon induction of differentiation with RPMI containing the GSK3β-inhibitor CHIR was analyzed by RT-qPCR. Shown are data points of three
independent experiments normalized to respective control values, means and p-values derived from t-tests. Note, depletion of p114RhoGEF attenuates induction of
the syncytiotrophoblast marker SynB. (E,F) Cells cultures as in panel (D) were analyzed by fluorescence microscopy upon labeling F-actin and DNA. An area
occupied by a large fused cell is demarked with a dashed line. The graph shows a quantification of the fusion index from four separate experiments (p-value based
on t-test). Note, fusion was inhibited by p114RhoGEF depletion. Bars: (A,B), 40 µm; (C), 1 mm; (E), 100 µm.
Increased mechanical tension and cytoskeletal remodeling are
thought to be required for cell-cell fusion (Kim et al., 2015;
Cong et al., 2019). Therefore, we asked whether p114RhoGEF
is required for forskolin-induced actomyosin remodeling.
Thirty minutes of forskolin stimulation induced preferential
accumulation of activated myosin (ppMLC) at tricellular contacts
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FIGURE 6 | p114RhoGEF is required for forskolin-induced CREB activation, cell-cell fusion and hormonogenesis. (A,B) Control and p114RhoGEF- or
AKAP12-depleted BeWo cells were treated with 100 µM forskolin for 48 h to induce cell-cell fusion and were then analyzed by immunofluorescence microscopy
after staining for DNA and E-Cadherin or ZO-1. In forskolin-treated control cells, areas of cell-cell fusion are indicated with white asterisks. Depletion of both
p114RhoGEF or AKAP12 strongly reduced cell-cell fusion as supported by the quantification of fusion index in (B) (Shown are data points and averages, and
p-values derived from Tukey HSD tests). (C) Forskolin-stimulated induction of the syncytiotrophoblast marker Gcm1 RNA is reduced in p114RhoGEF-depleted cells
(shown are data points of 3 independent experiments, means and p-values derived from t-tests). (D) Immunoblot analysis of forskolin-induced Gcm1 protein
expression. The numbers for expression levels relative to the respective control values are means derived from four experiments for p114RhoGEF and two
experiments for AKAP12. (E) Induction of nuclear localization of pCREB by a 30 min treatment with forskolin is inhibited by depletion of p114RhoGEF or AKAP12.
The graph shows a quantification of the mean fluorescent intensity (MFI) of the nuclei (shown are data points three independent experiments, means and p-values
(Continued)
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FIGURE 6 | Continued
derived from t-tests). (F) Immunoblots revealing induction of phosphorylation of the PKA-targets CREB (Ser-133) and VASP (Ser-239) after a 30 min incubation with
forskolin of cells transfected with either control, p114RhoGEF or AKAP12 siRNAs. The graph shows a quantification of the levels of phospho-CREB normalized to
levels observed in cells transfected with control siRNAs (shown are data points of three independent experiments, means and p-values derived from t-tests).
(G) CRE-luciferase reporter activity after a 120 min forskolin treatment of cells transfected with siRNAs as indicated. The values were normalized to control siRNA
transfected cells prior to induction for each experiment (shown are data points of four independent experiments, means and p-values derived from t-tests).
(H) Depletion of p114RhoGEF or AKAP12 attenuates forskolin-induced secretion of hCG (shown are data point from three independent experiments, means and
p-values derived from t-tests). (I) Depletion of p114RhoGEF or AKAP12 prevents.
(Figure 6I). p114RhoGEF depletion led to loss of junctional
actomyosin and induction of stress fibers, and forskolin
stimulation was no longer able to induce enrichment of active
myosin at tricellular contacts, a phenotype that was replicated by
AKAP12 depletion. Similarly, depletion of either p114RhoGEF
or AKAP12, reduced forskolin-induced increases in the levels of
phosphorylated VASP, a PKA substrate that regulates cytoskeletal
remodeling (Figure 6F). Thus, p114RhoGEF and AKAP12
are required for forskolin-induced actomyosin remodeling, in
agreement with p114RhoGEF’s role in activation of junctional
myosin contractility and the reduced phosphorylation of VASP,
a regulator of actin polymerization, in cells depleted of
p114RhoGEF or AKAP12.
DISCUSSION
The RhoA activator p114RhoGEF is essential for mammalian
development. A main role of p114RhoGEF during development
is to regulate differentiation of syncytiotrophoblasts, a cell type
essential for placenta development. p114RhoGEF’s function is
to coordinate actomyosin remodeling and AKAP12/PKA/CREB-
driven expression of syncytiotrophoblast-specific genes to enable
cell-cell fusion and syncytiotrophoblast differentiation.
Syncytiotrophoblasts are essential for development
of the labyrinth layer, the area of the placenta where
fetomaternal exchange occurs. Labyrinth development
depends on differentiation of specialized trophoblasts (e.g.,
syncytiotrophoblasts) and branching morphogenesis. Branching
morphogenesis is initiated by Gcm1-positive cell clusters within
the basal chorionic trophoblast layer that then guide fetal blood
vessels toward maternal blood sinuses (Walentin et al., 2016).
A key feature of the labyrinth is the development of two adjacent
multinucleated and terminally differentiated trophoblasts, SynT-I
and SynT-II cells, that arise by cell-cell fusion. These specialized
cells enable the formation of a barrier between maternal and
fetal blood vessels to regulate nutrient and gas exchange. Indeed,
it is well characterized that mouse mutants that show defects
in development of the labyrinth are embryonic lethal by mid-
gestation (Watson and Cross, 2005). Our results indicate that
the differentiation and fusion of syncytiotrophoblasts to form
the fetomaternal barrier is disrupted in p114RhoGEF knockout
mice. Syncytiotrophoblast fusion requires activation of the
PKA-CREB transcriptional pathway, leading to expression of the
fusogens SynA and SynB, and remodeling of the cytoskeleton
and cell-cell junctions (Gerbaud and Pidoux, 2015). Our data
indicate that p114RhoGEF promotes trophoblast cell fusion by
regulating AKAP12 and PKA-CREB-mediated transcription of
proteins required for cell-cell fusion as well as by stimulating
actin cytoskeleton reorganization.
Placenta defects are a common reason for embryonic lethality
in mouse mutants (Perez-Garcia et al., 2018). Nevertheless,
p114RhoGEF deficient embryos exhibited a number of
phenotypes, such as hemorrhages, that are compatible with
p114RhoGEF’s known role in junction formation and stability in
cell culture systems. Such phenotypes may also contribute to the
observed embryonic lethality. However, mice with an endothelial
specific knockout of p114RhoGEF are viable, indicating that
neither embryonic nor extraembryonic endothelia require
the GEF to support embryonic development and placenta
morphogenesis. It will be important to study the role of
p114RhoGEF in junction and tissue maintenance in adult
animals in response to tissue stress, which may contribute to the
understanding of how p114RhoGEF malfunction leads to human
disease (Xie et al., 2013; Arno et al., 2017).
Apart of the placenta, we did not observe striking
morphological defects in p114RhoGEF−/− embryos. Hence,
p114RhoGEF is required for placenta morphogenesis but not
morphogenetic processes in the embryo itself. This is similar
to mutant fish in which a p114RhoGEF null allele resulted
in viable fish that developed an eye defect due to a failure
not in generating but in maintaining cell polarity (Herder
et al., 2013). Placenta disruption by p114RhoGEF deficiency
occurred in response to defective trophoblast differentiation.
In trophoblast cultures, p114RhoGEF depletion reduced
AKAP12 and cAMP-stimulated PKA/CREB activation, actin
cytoskeleton rearrangements required for cell-cell fusion,
and expression of genes, such as Gcm1 SynA/B, required
for syncytiotrophoblast differentiation; all processes required
for placenta morphogenesis. Gcm1 is a transcription factor
regulating syncytiotrophoblast differentiation, and the Syn genes
encode the syncytins that mediate cell-cell fusion. Our data thus
indicate that p114RhoGEF coordinates AKAP12/PKA/CREP
signaling and myosin activation to coordinate cytoskeletal
remodeling and gene expression during cell-cell fusion and
syncytiotrophoblast differentiation.
p114RhoGEF regulates junction formation by driving
junctional myosin activation in cells in culture (Terry et al.,
2011). Here, we identify p114RhoGEF as a regulator of PKA
signaling and, thereby, CREB-regulated transcription and VASP
activation. In vitro and in vivo loss of function approaches
indicate that the RhoA exchange factor regulates expression
of AKAP12 and PKA/CREB target genes in trophoblasts
that are required for syncytiotrophoblast fusion (e.g.,
Gcm1, SynB, hCG) by attenuating phosphorylation and,
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thereby, activation of CREB. The spatial regulator of PKA
signaling by AKAP12 is downregulated by p114RhoGEF
depletion in in vitro models and in the placenta in vivo.
While AKAPs are thought to act as scaffolding proteins
that determine the spatial organization of PKA signaling,
how p114RhoGEF regulates expression of AKAP12 is not
clear yet.
Active p114RhoGEF forms complexes with Rock II and
myosin-IIA, which is important for its role in junction formation
and cell migration (Terry et al., 2010, 2012). Interestingly,
both Rock II and myosin-IIA are important for placenta
development. Knockout of myosin-IIA was reported to impact
on an earlier stage of placenta development than p114RhoGEF
deficiency, suggesting that different mechanisms of actomyosin
activation are involved at different stages of trophoblast linage
differentiation (Crish et al., 2013). Rock II is highly expressed
in the labyrinth layer and its deletion leads to disruption
of the architecture of the labyrinth layer (Thumkeo et al.,
2003). While overall F-actin architecture in the labyrinth layer
and stress fiber formation in trophoblasts in culture were
not affected by Rock II deficiency, myosin activity, cell-cell
junctions and cell-cell fusion in trophoblasts were not studied
in the Rock II knockout cells. Hence, it is not clear how
Rock II contributes to actomyosin activity in trophoblasts;
however, a role in gene expression was suggested (Thumkeo
et al., 2003). As our results indicate that p114RhoGEF, which
complexes with Rock II, regulates trophoblast gene expression,
the two proteins may cooperate in at least some functions
during trophoblast differentiation. The GTPase cycle not only
requires GEFs but also GAPs. DLC1, a GAP for RhoA and
Cdc42, is highly expressed in trophoblasts of the labyrinth, and
DLC1 knockout was reported to lead to defects in labyrinth
organization and angiogenesis; however, the underlying reasons
have not been analyzed (Durkin et al., 2005). It is possible,
that DLC1 may be a signaling partner of p114RhoGEF in
some processes as DLC1 was reported to stabilize cell-cell
junctions in cultured tumor cells (Tripathi et al., 2012). Another
signaling partner of p114RhoGEF, LKB1, was also linked to
placenta development, at least in part due upregulation of
VEGF secretion (Ylikorkala et al., 2001). In contrast to myosin
IIA and Rock II, LKB1 functions upstream of p114RhoGEF
by binding and activating the GEF in a kinase activity-
independent manner, which is important for junction formation
and morphogenesis of cultured epithelial cells (Xu et al., 2013).
However, whether LKB1 plays a role in trophoblasts and cell-cell
fusion is not known.
Other cell-cell junction proteins have previously been
linked to placenta development. Depletion of the cell-cell
adhesion genes connexin-31 or connexin-43 results in placental
abnormalities and developmental defects (Kibschull et al.,
2005; Dunk et al., 2012). Connexin-43 has been shown to
regulate cell-cell fusion and to form a complex with ZO-1
in trophoblasts (Pidoux et al., 2014). ZO-1 is required for
junctional recruitment of p114RhoGEF and, in primary
endothelial cells, ZO-1 depletion reduces cell-cell tension
due to loss of junctional p114RhoGEF (Terry et al., 2011;
Tornavaca et al., 2015). Although p114RhoGEF depletion in
trophoblast models did not prevent junctional recruitment
of ZO-1, the morphological appearance of the junctional
staining of ZO-1 indicated reduced cell-cell tension. This
was further supported by the observed striking remodeling
of the actomyosin cytoskeleton in p114RhoGEF-deficient
trophoblasts with a strong reduction in junction-associated
active myosin and an induction of stress fibers. Thus,
it is possible that the placenta defect of Connexin-43
depletion is mediated by reduced junctional recruitment of
p114RhoGEF.
Strikingly, p114RhoGEF was not only required for PKA-
stimulated cell-cell fusion but also for the rapid induction
of junctional foci of active myosin. Cytoskeletal remodeling
and the thereby generated mechanical tension are thought
to be key drivers of cell-cell fusion by promoting the close
proximity of the neighboring plasma membranes required
for fusion to occur (Kim et al., 2015; Cong et al., 2019). In
the placenta, tissue stiffness increases to levels that start to
attenuate cell-cell fusion in preeclampsia, a disease caused
by defective trophoblast differentiation, suggesting that
increased tissue stiffness may prevent the close membrane
approximation required for fusion (Kilic et al., 2015; Ma
et al., 2020). p114RhoGEF is required for tight junction
assembly when monolayers are under high mechanical
tension (Haas et al., 2020). As p114RhoGEF is required for
PKA-stimulated remodeling of the actin cytoskeleton along
cell-cell junctions prior to fusion, p114RhoGEF-deficient
trophoblasts may not be able to generate and maintain the
necessary close membrane-membrane contacts required
for membrane fusion. Hence, p114RhoGEF may regulate
placenta morphogenesis by modulating syncytiotrophoblast
differentiation via PKA-stimulated expression of genes as
well as by remodeling the actomyosin cytoskeleton to enable
cell-cell fusion.
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